Dopamine receptor D2 and D4 genes, GABA(A) alpha-1 subunit gene and response to lithium prophylaxis in mood disorders

Psychiatry Research

Volumn 87, Issue 1, 1999, Pages 7-19

  Serretti, Alessandro ^a   Lilli, Roberta ^a   Lorenzi, Cristina ^a   Franchini, Linda ^a   Di Bella, Daniela ^a   Catalano, Marco ^a   Smeraldi, Enrico ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Bipolar disorder; Dopamine receptor D2; Dopamine receptor D4; Follow up studies; GABA(A) receptors; Genetics; Treatment outcome

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 4 RECEPTOR; LITHIUM;

ADULT; AFFECTIVE NEUROSIS; ARTICLE; DEPRESSION; FEMALE; FOLLOW UP; GENE; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIC DEPRESSIVE PSYCHOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; ANALYSIS OF VARIANCE; BIPOLAR DISORDER; CHI-SQUARE DISTRIBUTION; DEPRESSIVE DISORDER; DRUG RESISTANCE; FEMALE; GENETIC MARKERS; GENOTYPE; HAPLOTYPES; HUMANS; LITHIUM; MALE; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D4; RECEPTORS, GABA-A; RECURRENCE; TREATMENT OUTCOME;

EID: 0032828965     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(99)00056-6     Document Type: Article

References (91)

1. Abou-Saleh M.T. Who responds to prophylactic lithium therapy? British Journal of Psychiatry. Supplement 21:1993;20-26.
2. Acquas E., Fibiger H.C. Chronic lithium attenuates dopamine D1-receptor mediated increases in acetylcholine release in rat frontal cortex. Psychopharmacology. 125:1996;162-167.
3. Arinami T., Itokawa M., Aoki J., Shibuya H., Ookubo Y., Iwawaki A., Ota K., Shimizu H., Hamaguchi H., Toru M. Further association study on dopamine D2 receptor variant S311C in schizophrenia and affective disorders. American Journal of Medical Genetics. 67:1996;133-138.
4. Arinami T., Itokawa M., Enguchi H., Tagaya H., Yano S., Shimizu H., Hamaguchi H., Toru M. Association of dopamine D2 receptor molecular variant with schizophrenia. Lancet. 343:1994;703-704.
5. Asghari V., Sanyal S., Buchwaldt S., Paterson A., Jovanovic V., Van Tol H. Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. Journal of Neurochemistry. 65:1995;1157-1165.
6. Balk J., Picetti R., Salardi A., Thirlet G., Dierich A., Depaulls A., Le Meur M., Borrelli E. Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature. 377:1995;424-428.
7. Barbini B., Scherillo P., Benedetti F., Crespi G., Colombo C., Smeraldi E. Response to clozapine in acute mania is more rapid than that of chlorpromazine. International Clinical Psychopharmacology. 12:1997;109-112.
8. Barbujani G., Sokal R.R. Genetic population structure of Italy. I. Geographic patterns of gene frequencies. Human Biology. 63:1991;253-272.
9. Barnes J.C., Costall B., Domeney A.M., Naylor R.J. Lithium and bupropion antagonise the phasic changes in locomotor activity caused by dopamine infused into the rat nucleus accumbens. Psychopharmacology. 89:1986;311-316.
10. Belmaker R.H., Bersudsky Y., Agam G., Levine J., Kofman O. How does lithium work on manic depression? Clinical and psychological correlates of the inositol theory. Annual Review of Medicine. 47:1996;47-56.
11. Bradley C., Blakely R. Alternative splicing of the human serotonin transporter gene. Journal of Neurochemistry. 69:1997;1356-1367.
12. Byerley W., Bailey M., Hicks A., Riley B., Darlison M., Holik J., Hoff M., Umar F., Reimherr F., Wender P. et al. Schizophrenia and GABAA receptor subunit genes. Psychiatric Genetics. 5:1995;23-29.
13. Byerley W., Leppert M., O'Connell P., Mellon C., Holik J., Lubbers A., Bullen K., Reimherr F., Grosser B., Wender P., Bunzow J., Grandy D., Litt M., Civelli O., Lalouel J., White R. D2 dopamine receptor not linked to manic-depression in three families. Psychiatric Genetics. 1:1990;55-62.
14. Calabrese J., Kimmel S., Woyshville M., Rapport D., Faust C., Thompson P., Meltzer H. Clozapine for treatment-refractory mania. American Journal of Psychiatry. 153:1996;759-764.
15. Carli M., Morissette M., Hebert C., Di Paolo T., Reader T.A. Effects of a chronic lithium treatment on central dopamine neurotransporters. Biochemical Pharmacology. 54:1997;391-397.
16. Cavazzoni P., Alda M., Turecki G., Rouleau G., Grof E., Martin R., Duffy A., Grof P. Lithium-responsive affective disorders: no association with the tyrosine hydroxylase gene. Psychiatry Research. 64:1996;91-96.
17. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 1988;Lawrence Erlbaum Associates, Publishers, Hillsdale, N.J.
18. Coon H., Hicks A., Bailey M., Hoff M., Holik J., Harvey R., Johnson K., Darlison M., Reimherr F., Wender P. et al. Analysis of GABAA receptor subunit genes in multiplex pedigrees with manic depression. Psychiatric Genetics. 4:1994;185-191.
19. Craddock N., Roberts Q., Williams N., McGuffin P., Owen M.J. Association study of bipolar disorder using a functional polymorphism (Ser311→Cys) in the dopamine D2 receptor gene. Psychiatric Genetics. 5:1995;63-65.
20. Cravchik A., Sibley D.R., Gejman P.V. Functional analysis of the human D2 dopamine receptor missense variants. Journal of Biological Chemistry. 271(42):1996;26013-26017.
21. Debruyn A., Souery D., Mendelbaum K., Mendlewicz J., Van Broeckhoven C. A linkage study between bipolar disorder and genes involved in dopaminergic and GABAergic neurotransmission. Psychiatric Genetics. 6:1996;67-73.
22. Debruyn A., Mendelbaum K., Sandkuijl L., Delvenne V., Hirsch D., Staner L., Mendlewicz J., Van Broeckhoven C. Non-linkage of bipolar illness to tyrosine hydroxylase, tyrosinase, and D2 and D4 dopamine receptor genes on chromosome 11. American Journal of Psychiatry. 151:1994;102-106.
23. Diehl D., Gershon S. The role of dopamine in mood disorders. Comprehensive Psychiatry. 2:1992;115-120.
24. Dziedzicka-Wasylewska M., Mackowiak M., Fijat K., Wedzony K. Adaptive changes in the rat dopaminergic transmission following repeated lithium administration. Journal of Neural Transmission-General Section. 103:1996;765-776.
25. El-Mallakh S. Litihum: actions and mechanisms. Spiegel D. Progress in Psychiatry. 1996;49-86 American Psychiatric Press, Washington, DC.
26. Endicott J., Spitzer R. A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia. Archives of General Psychiatry. 35:1978;837-844.
27. Franchini L., Gasperini M., Smeraldi E. A 24-month follow-up study of unipolar subjects: a comparison between lithium and fluvoxamine. Journal of Affective Disorders. 32:1994;225-231.
28. Franchini L., Zanardi R., Gasperini M., Perez J., Smeraldi E. Fluvoxamine and lithium in long-term treatment of unipolar subjects with high recurrence rate. Journal of Affective Disorders. 38:1996;67-69.
29. Fuciarelli M., Vienna A., Paba E., Bastianini A., Sansonetti B., Capucci E., Destefano G.F. PI, GC, HP, and TF serum protein polymorphisms in Siena, Tuscany, Italy, with a review of data for Italy. American Journal of Human Biology. 9:1997;629-646.
30. Gasparini P., Estivill X., Volpini V., Totaro A., Castellvi-Bel S., Govea N., Mila M., Della Monica M., Ventruto V., De Benedetto M., Stanziale P., Zelante L., Mansfield E.S., Sandkuijl L., Surrey S., Fortina P. Linkage of DFNB1 to non-syndromic neurosensory autosomal-recessive deafness in Mediterranean families. European Journal of Human Genetics. 5:1997;83-88.
31. Gasperini M., Scherillo P., Manfredonia M., Franchini L., Smeraldi E. A study of relapses in subjects with mood disorder on lithium treatment. European Neuropsychopharmacology. 3:1993;103-110.
32. Gelenberg A.J., Carroll J.A., Baudhuin M.G., Jefferson J.W., Greist J.H. The meaning of serum lithium levels in maintenance therapy of mood disorders: a review of the literature. Journal of Clinical Psychiatry. 50:1989;17-22.
33. Goldberg J.F., Harrow M., Leon A.C. Lithium treatment of bipolar affective disorders under naturalistic follow-up conditions. Psychopharmacology Bulletin. 32:1996;47-54.
34. Goodwin F., Jamison K. Manic-Depressive Illness. 1990;Oxford University Press, New York.
35. Gottberg E., Grondin L., Reader T.A. Acute effects of lithium on catecholamines, serotonin, and their major metabolites in discrete brain regions. Journal of Neuroscience Research. 22:1989;338-345.
36. Gottberg E., Montreuil B., Reader T.A. Acute effects of lithium on dopaminergic responses: iontophoretic studies in the rat visual cortex. Synapse. 2:1988;442-449.
37. Grandy D., Litt M., Allen L., Bunzow J., Marchionni M., Makam H., Reed L., Magenis R., Civelli O. The human D2 dopamine receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP. American Journal of Human Genetics. 45:1989;778-785.
38. Grof P., Alda M., Grof E., Zvolsky P., Walsh M. Lithium response and genetics of affective disorders. Journal of Affective Disorders. 32:1994;85-95.
39. Hauge X.Y., Grandy D.K., Eubanks J.H., Evans G.A., Civelli O., Litt M. Detection and characterization of additional DNA polymorphisms in the dopamine D2 receptor gene. Genomics. 10:1991;527-530.
40. Holmes D., Brynjolfsson J., Brett P., Curtis D., Petursson H., Sherrington R., Gurling H. No evidence for a susceptibility locus predisposing to manic depression in the region of the dopamine D2 receptor gene. British Journal of Psychiatry. 158:1991;635-641.
41. Itokawa M., Arinami T., Futamura N., Hamaguchi H., Toru M. A structural polymorphism of human dopamine D2 receptor, D2(Ser311→Cys). Biochemical and Biophysical Research Communications. 196:1993;1369-1375.
42. Johnson K., Sander T., Hicks A., Van Marle A., Janz D., Mullan M., Riley B., Darlison M. Confirmation of the localization of the human GABA-A 1 subunit gene (GABRA 1) to distal 5q by linkage analysis. Genomics. 14:1992;745-748.
43. Jönsson E., Sedvall G., Brene S., Gustavsson J.P., Geijer T., Terenius L., Crocq M.A., Lannfelt L., Tylec A., Sokoloff P., Schwartz J.C., Wiesel F.A. Dopamine-related genes and their relationships to monoamine metabolites in CSF. Biological Psychiatry. 40:1996;1032-1043.
44. Korpi E., Kleingoor C., Kettenmann H., Seeburg P. Benzodiazepine-induced motor impairment linked to point mutation in cerebellar GABA-A receptor. Nature. 361:1993;356-359.
45. Lahiri D., Nurnberger J.J. A rapid non-enzimatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acid Research. 19:1991;5444.
46. Lim L., Nöthen M., Körner J., Rietschel M., Castle D., Hunt N., Propping P., Murray R., Gill M. No evidence of association between dopamine D4 receptor variants and bipolar affective disorder. American Journal of Medical Genetics. 54:1994;259-263.
47. Lipp, O., Mahieu, B., Souery, D., Serretti, A., Cavallini, C., Verga, M., Van Broeckhoven, C., Macciardi, F., Mendlewicz, J., 1997. Molecular genetics of bipolar disorders: implication for psychotropic drugs. In: Xth Congress of the European College of Neuropsychopharmacology, Vienna, Austria.
48. Macciardi F., Petronis A., Van Tol H., Marino C., Cavallini M., Smeraldi E., Kennedy J. Analysis of the D4 dopamine receptor gene variant in an Italian schizophrenia kindred. Archives of General Psychiatry. 51:1994;288-293.
49. Maj M., Arena F., Lovero N., Pirozzi R., Kemali D. Factors associated with response to lithium prophylaxis in DSM III major depression and bipolar disorder. Pharmacopsychiatry. 18:1985;309-313.
50. Maj M., Del Vecchio M., Starace F., Pirozzi R., Kemali D. Prediction of affective psychoses response to lithium prophylaxis. The role of socio-demographic, clinical, psychological and biological variables. Acta Psychiatrica Scandinavica. 69:1984;37-44.
51. Maj M., Pirozzi R., Magliano L., Bartoli L. Long-term outcome of lithium prophylaxis in bipolar disorder: a 5-year prospective study of 402 patients at a lithium clinic. American Journal of Psychiatry. 155:1998;30-35.
52. Maj M., Pirozzi R., Starace F. Previous pattern of course of the illness as a predictor of response to lithium prophylaxis in bipolar patients. Journal of Affective Disorders. 17:1989;237-241.
53. Manki H., Kanba S., Muramatsu T., Higuchi S., Suzuki E., Matsushita S., Ono Y., Chiba H., Shintani F., Nakamura M., Yagi G., Asai M. Dopamine D2, D3 and D4 receptor and transporter gene polymorphisms and mood disorders. Journal of Affective Disorders. 40:1996;7-13.
54. McGuffin P., Farmer A., Harvey I. A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. Archives of General Psychiatry. 48:1991;764-770.
55. Mendlewicz J., Fieve R.R., Stallone F., Fleiss J.L. Genetic history as a predictor of lithium response in manic-depressive illness. Lancet. 1:1972;599-600.
56. Merchant K.M., Gill G.S., Harris D.W., Huff R.M., Eaton M.J., Lookingland K., Lutzke B.S., McCall R.B., Piercey M.F., Schreur P.J., Sethy V.H., Smith M.W., Svensson K.A., Tang A.H., Vonvoigtlander P.F., Tenbrink R.E. Pharmacological characterization of U-101387, a dopamine D4 receptor selective antagonist. Journal of Pharmacology and Experimental Therapeutics. 279:1996;1392-1403.
57. Mitchell P., Selbie L., Waters B., Donald J., Vivero C., Tully M., Shine J. Exclusion of close linkage of bipolar disorder to the dopamine D1 and D2 receptor gene markers. Journal of Affective Disorders. 25:1992;1-12.
58. Morabito A., Gasperini M., Macciardi F., Smeraldi E. Possible relationship between outcome in primary affective disorders treated with lithium and family history. Advances in Biochemical Psychopharmacology. 32:1982;157-163.
59. Mrzljak L., Bergson C., Pappy M., Huff R., Levenson R., Goldman-Rakic P. Localization of dopamine D4 receptors in GABAergic neurons of the primate brain. Nature. 381:1996;245-248.
60. Nanko S., Fukuda R., Hattori M., Sasaki T., Dai X., Kanba S., Kato T., Kazamatsuri H. Linkage studies between affective disorder and dopamine D2, D3, and D4 receptor gene loci in four Japanese pedigrees. Psychiatry Research. 52:1994;149-157.
61. Nöthen M., Erdmann J., Körner J., Lanczik M., Fritze J., Fimmers R., Grandy D., O'Dowd B., Propping P. Lack of association between dopamine D1 and D2 receptor genes and bipolar affective disorder. American Journal of Psychiatry. 149:1992;199-201.
62. O'Connell R.A., Mayo J.A., Flatow L., Cuthbertson B., O'Brien B.E. Outcome of bipolar disorder on long-term treatment with lithium. British Journal of Psychiatry. 159:1991;123-129.
63. Oruc L., Furac I., Croux C., Jakovljevic M., Kracun I., Folnegovic V., Van Broeckhoven C. Association study between bipolar disorder and candidate genes involved in dopamine-serotonin metabolism and GABAergic neurotransmission: a preliminary report. Psychiatric Genetics. 6:1996;213-217.
64. Oruc L., Verheyen G.R., Furac I., Jakovljevic M., Ivezic S., Raeymaekers P., Van Broeckhoven C. Analysis of the tyrosine hydroxylase and dopamine D4 receptor genes in a Croatian sample of bipolar I and unipolar patients. American Journal of Medical Genetics. 74:1997;176-178.
65. Page C., Benaim S., Lappin F. A long-term retrospective follow-up study of patients treated with prophylactic lithium carbonate. British Journal of Psychiatry. 150:1987;175-179.
66. Perez de Castro I., Santos J., Torres P., Visedo G., Saiz-Ruiz J., Llinares C., Fernandez-Piqueras J. A weak association between TH and DRD2 genes and bipolar affective disorder in a Spanish sample. Journal of Medical Genetics. 32:1995;131-134.
67. Petty F. GABA and mood disorders: a brief review and hypothesis. Journal of Affective Disorders. 34:1995;275-281.
68. Post R.M., Weiss S.R. The neurobiology of treatment-resistant mood disorders. Bloom F.E., Kupfer D.J. Psychopharmacology: The Fourth Generation of Progress. 1995;1155-1170 Raven Press, New York.
69. Pritchett D., Seeburg P. Gamma-aminobutyric acid type A receptor point mutation increases the affinity of compounds for the benzodiazepines site. Proceedings of the National Academy of Sciences USA. 88:1991;1421-1425.
70. Richelson E. Cholinergic transduction. Bloom F.E., Kupfer D.J. Psychopharmacology: The Fourth Generation of Progress. 1995;125-134 Raven Press, New York.
71. Rubinstein M., Phillips T.J., Bunzow J.R., Falzone T.L., Dziewczapolski G., Zhang G., Fang Y., Larson J.L., McDougall J.A., Chester J.A., Saez C., Pugsley T.A., Gershanik O., Low M.J., Grandy D.K. Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine, and methamphetamine. Cell. 90:1997;991-1001.
72. Schou M. Lithium Treatment of Manic-Depressive Illness: A Practical Guide. 1989;Karger, Basel.
73. Serretti A., Lilli R., Lorenzi C., Gasperini M., Smeraldi E. Dopamine receptor D3 gene and response to lithium prophylaxis in mood disorders. International Journal of Neuropsychopharmacology. 1:1998;125-129.
74. Serretti A., Macciardi F., Cusin C., Lattuada E., Lilli R., Bella D.D., Catalano M., Smeraldi E. No interaction of GABA(A) alpha-1 subunit and dopamine receptor D4 exon 3 genes in symptomatology of major psychoses. American Journal of Medical Genetics. 88:1999;44-49.
75. Serretti A., Macciardi F., Smeraldi E. Dopamine receptor D2 Ser Cys311 variant associated with disorganized symptomatology of schizophrenia. Schizophrenia Research. 34:1998;207-210.
76. Smeraldi E., Petroccione A., Gasperini M., Macciardi F., Orsini A. The search for genetic homogeneity in affective disorders. Journal of Affective Disorders. 7:1984;99-107.
77. Smeraldi E., Petroccione A., Gasperini M., Macciardi F., Orsini A., Kidd K.K. Outcomes on lithium treatment as a tool for genetic studies in affective disorders. Journal of Affective Disorders. 6:1984;139-151.
78. Smith M., Wasmuth J., McPherson J., Wagner C., Grandy D., Civelli O., Potkin S., Litt M. Cosegregation of an 11q22.3-9q22 translocation with affective disorder: proximity of the dopamine D2 receptor gene relative to the translocation breakpoint. American Journal of Human Genetics. Suppl. 45:1989;A220.
79. Solomon D.A., Keller M.B., Leon A.C., Mueller T.I., Shea M.T., Warshaw M., Maser J.D., Coryell W., Endicott J. Recovery from major depression: a 10-year prospective follow-up across multiple episodes. Archives of General Psychiatry. 54:1997;1001-1006.
80. Souery D., Lipp O., Mahieu B., Mendelbaum K., De Martelaer V., Van Broeckhoven C., Mendlewicz J. Association study of bipolar disorder with candidate genes involved in catecholamine neurotransmission: DRD2, DRD3, DAT1, and TH genes. American Journal of Medical Genetics. 67:1996;551-555.
81. Souery D., Lipp O., Serretti A., Mahieu B., Rivelli S.K., Cavallini C., Ackenheil M., Adolfsson R., Aschauer H., Blackwood D., Dam H., Delcoigne B., Demartelaer V., Dikeos D., Fuchshuber S., Heiden M., Jablensky A., Jakovljevic M., Kessing L., Lerer B., Macedo A., Mellerup T., Milanova V., Muir W., Mendlewicz J. et al. European Collaborative Project on Affective Disorders: interactions between genetic and psychosocial vulnerability factors. Psychiatric Genetics. 8:1998;197-205.
82. Tang A.H., Franklin S.R., Himes C.S., Smith M.W., Tenbrink R.E. PNU-96415E, a potential antipsychotic agent with clozapine-like pharmacological properties. Journal of Pharmacology and Experimental Therapeutics. 281:1997;440-447.
83. Terwilliger J., Ott J. Handbook for Human Genetic Linkage. 1994;Johns Hopkins University Press, Baltimore.
84. Turecki G., Alda M., Grof P., Martin R., Cavazzoni P.A., Duffy A., Maciel P., Rouleau G.A. No association between chromosome-18 markers and lithium-responsive affective disorders. Psychiatry Research. 63:1996;17-23.
85. van Kammen D.P., Docherty J.P., Marder S.R., Rosenblatt J.E., Bunney W.E. Jr. Lithium attenuates the activation-euphoria but not the psychosis induced by d-amphetamine in schizophrenia. Psychopharmacology. 87:1985;111-115.
86. Van Tol H., Bunzow J., Guan H., Sunahara R., Seeman P., Niznik H., Civelli O. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature. 350:1991;610-614.
87. Van Tol H., Caren M., Guan H., Ohara K., Bunzow J., Civelli O., Kennedy J., Seeman P., Niznik H., Jovanovic V. Multiple dopamine D4 receptor variants in the human population. Nature. 358:1992;149-152.
88. Wafford K., Burnett D., Leidenheimer N., Burt D., Wang J., Kofuji P., Dunwiddie T., Harris R., Sikela J. Ethanol sensitivity of the GABA-A receptor expressed in Xenopus oocytes requires eight amino acids contained in the gamma-2L subunit. Neuron. 7:1991;27-33.
89. Walsh C., Hicks A., Sham P., Castle D., Hunt N., Clements A., Sander T., Murray R., Darlison M., Gill M. GABA-A receptor subunit genes as candidate genes for bipolar affective disorder; an association analysis. Psychiatric Genetics. 2:1992;239-247.
90. Willner P. Dopaminergic mechanisms in depression and mania. Bloom F.E., Kupfer D.J. Psychopharmacology: The Fourth Generation of Progress. 1995;921-931 Raven Press, New York.
91. Zarate C.A. Jr., Tohen M., Banov M.D., Weiss M.K., Cole J.O. Is clozapine a mood stabilizer? Journal of Clinical Psychiatry. 56:1995;108-112.